drugset / Trial / NCT00170690
Preference Study With Elderly Patients Recurrent Ovarian Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Comparison of the patient compliance treosulfan oral vs. intravenous (defined as end of therapy for the patient)
Timeline
- Start
- 2004-08
- Primary completion
- 2011-12
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treosulfan | Small molecule | 600 mg/m2 | Oral |
| Subject | Treosulfan | Small molecule | 7000 mg/m2 | Oral |